Opinion

Video

Differential Diagnoses of IgAN

Author(s):

Jonathan Barratt, PhD, FRCP,Anuja Java, MD

Key Takeaways

  • IgA nephropathy diagnosis involves clinical evaluation, laboratory tests, and renal biopsy to differentiate from similar glomerular diseases.
  • Renal biopsy with immunofluorescence microscopy is crucial, revealing mesangial IgA deposits specific to IgAN.
SHOW MORE

Panelists discuss how clinicians can differentiate IgA nephropathy from other glomerular diseases, such as lupus nephritis and membranous nephropathy, that may present with similar clinical features.

  1. How do clinicians differentiate IgANIgA nephropathy from other glomerular diseases, such as lupus nephritis or membranous nephropathy, which can present with similar clinical features?
Related Videos
How to Manage Aspirin-Exacerbated Respiratory Disease
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
4 experts are featured in this series.
4 experts are featured in this series.
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Related Content
Ankeet Bhatt, MD, MBA, ScM | Credit: American Heart Association
November 17th 2024

Understanding NUDGLE-FLU Data from AHA 2024, with Ankeet Bhatt, MD, MBA, ScM

Ankeet Bhatt, MD, MBA Patrick Campbell
Kidney Compass: Atacicept for IgAN with Jonathan Barratt, MD, PhD, at Kidney Week 2024
October 27th 2024

Kidney Compass: Atacicept for IgAN with Jonathan Barratt, MD, PhD, at Kidney Week 2024

Brendon Neuen, MBBS, PhD Shikha Wadhwani, MD, MS
Ellen Sher, MD | Credit: Allergy Partners
November 11th 2024

Ellen Sher, MD: Cross-Specialty Collaboration Can Improve Atopic Dermatitis Management

Ellen Sher, MD Patrick Campbell
MEDCast Podcast logo
October 1st 2024

Exploring Oral Systemic Therapies for Plaque Psoriasis: Efficacy, Safety, and Clinical Considerations

Lauren Miller, MPAS, PA-C Jayme M Heim, MSN, FNP-BC Kirk Gautier, PA-C
Jonathan Barratt, PhD | Credit: IgA Nephropathy Foundation
October 27th 2024

ORIGIN OLE Data Solidify Atacicept Disease-Modifying Potential for IgA Nephropathy

Patrick Campbell
Finnian McCausland, MBBCh | Credit: Mass General Brigham
October 25th 2024

Finerenone Use Reduces UACR, New-Onset Macroalbuminuria in Heart Failure Patients

Patrick Campbell
© 2024 MJH Life Sciences

All rights reserved.